Zevra Therapeutics (ZVRA) EPS (Basic) Growth (3y) (2017 - 2026)
Zevra Therapeutics (ZVRA) EPS (Basic) Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
41.58% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
85.94% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Zevra Therapeutics |
796.95 Mn |
596.33 Mn |
34.30 Mn |
53.71% |
| Date | Value |
|---|
| Mar 31, 2026 |
53.71% |
| Dec 31, 2025 |
61.63% |
| Sep 30, 2025 |
69.71% |
| Jun 30, 2025 |
57.91% |
| Mar 31, 2025 |
-29.49% |
| Dec 31, 2024 |
-150.93% |
| Sep 30, 2024 |
-139.86% |
| Jun 30, 2024 |
-6.27% |
| Mar 31, 2024 |
45.64% |
| Dec 31, 2023 |
21.82% |
| Sep 30, 2023 |
23.87% |
| Jun 30, 2023 |
-33.53% |
| Mar 31, 2023 |
41.72% |
| Dec 31, 2022 |
80.73% |
| Sep 30, 2022 |
-81.71% |
| Jun 30, 2022 |
-24.71% |
| Mar 31, 2022 |
40.29% |
| Dec 31, 2021 |
-34.75% |
| Sep 30, 2021 |
62.39% |
| Jun 30, 2021 |
14.94% |
